Suchergebnisse - "Partin, Alan W."

PubPharm (814)

91

Role of biobanking in urology: a review

enthalten in: BJU international | 2016

von Chalfin, H. | Fabian, E. | Mangold, L. | +3

92

Pathological analysis of the prostatic anterior fat pad at radical prostatectomy: insights from a prospective series

enthalten in: BJU international | 2016

von Ball, M. | Harris, K. | Schwen, Z. | +5

93

An Approach Using PSA Levels of 1.5 ng/mL as the Cutoff for Prostate Cancer Screening in Primary Care

enthalten in: Urology | 2016

von Crawford, E. | Rosenberg, M. | Partin, A. | +15

94

Risk score predicts high‐grade prostate cancer in DNA‐methylation positive, histopathologically negative biopsies

enthalten in: The prostate | 2016

von Van Neste, L. | Partin, A. | Stewart, G. | +3

95

Prostate Health Index improves multivariable risk prediction of aggressive prostate cancer

enthalten in: BJU international | 2016

von Loeb, S. | Shin, S. | Broyles, D. | +11

96

SPINK1 Defines a Molecular Subtype of Prostate Cancer in Men with More Rapid Progression in an at Risk, Natural History Radical Prostatectomy Cohort

enthalten in: The journal of urology | 2016

von Johnson, M. | Ross, A. | Alshalalfa, M. | +12

97

The Impact of Downgrading from Biopsy Gleason 7 to Prostatectomy Gleason 6 on Biochemical Recurrence and Prostate Cancer Specific Mortality

enthalten in: The journal of urology | 2016

von Ham, W. | Chalfin, H. | Feng, Z. | +6

98

New Prostate Cancer Grading System Predicts Long-term Survival Following Surgery for Gleason Score 8–10 Prostate Cancer

enthalten in: European urology | 2016

von Ham, W. | Chalfin, H. | Feng, Z. | +6

99

An Approach Using PSA Levels of 1.5 ng/mL as the Cutoff for Prostate Cancer Screening in Primary Care

enthalten in: Urology | 2016

von Crawford, E. | Rosenberg, M. | Partin, A. | +15

100

Role of biobanking in urology: a review

enthalten in: BJU international | 2016

von Chalfin, H. | Fabian, E. | Mangold, L. | +3